Home›Companies›Healthcare›Evolve Medicus

Evolve Medicus, Inc.

Develops a dialysis access device for patients and their caregivers.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing May 12, 2026·Suggest an edit

About Evolve Medicus

Evolve Medicus is a private company based in The Woodlands, Texas, incorporated in 2022 in Delaware. It has reported $2,245,000 raised in one offering on Form D since May 2026. Its chief executive is Ouadie Akaaboune.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 15, 2026May 12, 2026$2,245,000of $3.0M target23$97,609Equity, Securities on exercise, SAFE (simple agreement for future equity)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Evolve Medicus's Form D filed May 12, 2026.

OA
Ouadie Akaaboune
Chief Executive Officer and director
Mark Mettauer
Mark Mettauer
OnePoint Dialysis Cannula Inventor and director

Sources

  1. SECEvolve Medicus, Inc. filing history